Type One Diabetes: New Hope and Treatments

0:00In Durham, it's March 1st. Here's what is happening. Type 1 diabetes affects about 2.1 million people in the United States, making up around 5% of all diabetes cases. While most diabetics have Type 2, this autoimmune condition is on the rise, showing up more in both kids and adults for reasons experts are still. Unpacking. Common symptoms hit hard and fast, like constant thirst, unexplained weight loss, fatigue, frequent urination, and even nausea that feels like the flu. People might feel ravenously hungry too, yet keep shedding pounds, and without quick treatment, it can lead to confusion or coma. The impact is huge, forcing lifelong insulin dependence since the body stops making it. Current tech like continuous glucose monitors and insulin pumps has transformed daily management, giving patients safer lives and fewer complications. Compared to 20 years ago, a big step forward is a drug approved in 2023 that can delay Type 1 onset by 2 to

1:013 years in high risk folks. For some, I let cell transplants from deceased donors act as a cure, though they require immunosuppressive drugs to prevent rejection. Looking ahead, doctors like Baytool Hetzaboglu from university hospitals predict game changers in the next 5 to 10 years, including transplants. Without those risky drugs, the momentum is building toward broader cures and prevention, bringing real hope to millions. This story is made possible by our sponsor. When you need a moment alone, just lay back and listen.